PFE
Who in Congress traded PFE, when, and what happened after?
A ticker-first view for retail/data users: latest disclosure, largest range, disclosure lag, party flow, contracts, lobbying, and source-linked receipts.
Party Breakdown
Party Trading Divergence
Democrat vs. Republican buy / sell pressure by monthALIGNEDBar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.
🏛️ Federal Contracts
all →- 2026-06-08$359KDepartment of Health and Human ServicesVACCINES FOR ADULTS EO 14398
- 2026-05-29$4.6MDepartment of Health and Human ServicesFY26-27 PEDIATRIC COVID VACCINES EO 14398
- 2026-05-29$381KDepartment of Health and Human ServicesFY 26-27 ADULT COVID VACCINES EO 14398
- 2026-05-15$543KDepartment of Health and Human ServicesSTERILE WATER FOR INJECTION, 20ML
- 2026-03-27$187.6MDepartment of Health and Human ServicesVACCINES FOR CHILDREN
💼 Lobbying Filings
all →- 2026-04-20$150KPFIZER INC.Medicare and healthcare policy issues as they relate to drug pricing. Oppose IRA, PREP Act and vaccine liability. General issues with tax reform and foreign tax issues. Issues related to drug consolidation.
- 2026-04-20$60KPFIZERDrug pricing and prescription digital therapeutics
- 2026-04-20$60KPFIZER INCProvide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally and/or Pfizer specifically.
- 2026-04-20$60KPFIZERGeneral education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; drug importation; and drug shortages. Drug pricing proposals. The 340B program. Pharmacy benefit manager reform proposals, issues related to headache and migraine. P.L. 119-21. Tax issues affecting the pharmaceutical industry including international tax; implementation of PL 119-21. Vaccine excise tax issues and VICP. Medicare payment issues and Medicaid issues. Medicare Part D. Drug pricing proposals. Protecting Seniors Through Immunization Act. Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN. P.L. 119-21. Issues related to pharmaceutical manufacturing and development, trade and tariffs; potential tariff actions under Section 232 of the Trade Act of 1962. Policies impacting post pandemic public health emerge
- 2026-04-20$60KPFIZER INC.Issues related to FY27 health appropriations Issues related to 340B Program Issues related to drug pricing
- 2026-04-20$60KPFIZERIssues related to drug development and pricing, generally vaccine safety and access, generally the 340B program, Issues related to pharmacy benefit managers, generally. H.R. 5509, the Safe Step Act Direct-to-Patient Prescription Drug Purchase Platforms Most Favored Nation drug pricing 340B HHS Pilot Program Model
- 2026-04-20$60KPFIZER INC.Issues related to FDA regulation of pharmaceuticals. Drug pricing and Medicare, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. Issues related to intellectual property and patent reform, including: S.1040, Drug Competition Enhancement Act; S.1041; Affordable Prescriptions for Patients Act. Vaccine Policy, Coverage and Access and the Vaccine Injury Compensation Fund. H.R.2214 - DRUG Act. Issues related to tariff and trade policy. International Supply Chain. Issues related to tariff and trade policy.
- 2026-04-20$50KPFIZER INC
- 2026-04-17$4.4MPFIZER INC.Intellectual Property Protections Vaccine Coverage Pediatric Immunization Schedule Vaccine Injury Compensation Program Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients H.R. 7837 - Most Favored Patient Act of 2026 Lyme Disease Issues 340B Issues Counterfeit Drugs Inflation Reduction Act (IRA) Prescription Drug User Fee Act (PDUFA) Drug Pricing PBM Reform Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage H.R. 5509 - Safe Step Act S. 2903 - Safe Step Act S. 3510 - Biosimilar Inspection Modernization Act of 2025 Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Prescription Drug User Fee Act (PDUFA) 340B Issues Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage PBM Reform Counterfeit Drugs P.L. 117-169 - Inflation Reduction Act (IRA) of 2022 Drug Pricing Medicare/Medicaid Issues International Supply Chain Market Access Most Fa
- 2026-04-17$60KPFIZER INC.Issues related to tariff and trade policy. Issues related to vaccine excise taxes and the Vaccine Injury Compensation Fund. Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. H.R. 1492, to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. Issues related to vaccine development, distribution and injury compensation. Issues related to FDA regulation of pharmaceuticals. Issues related to prescription drug pricing and pharmacy benefit manager business practices, including Division J of H.R.7148 - Consolidated Appropriations Act, 2026, PL 119-75. Issues related to the 340B program. Issues related to intellectual property and patent reform, including: S.1040, Drug Competition Enhancement Act; S.1041, Affordable Prescriptions for Patie
Congressional Momentum
buy vs. sell pressureACCUMULATINGScore 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.
Best Timers
avg excess return vs SPY · PFE trades only18 members w/ alpha dataExcess return = stock price change minus SPY change over the same holding window.Congress avg: -18.5%· 6% of traders beat SPY on this name
Timing Fingerprint
filing delay vs. excess return over SPY · 64 tradesCongress avg -18.2% vs SPYEach dot = one disclosed trade. X-axis = days between trade and STOCK Act filing.Y-axis = return above (or below) SPY over the subsequent holding window. Upper-right = late filers who beat the market.
Congress Swarm Events
synchronized trading — 3+ members within 21 daysSUSPICIOUSA swarm event occurs when 3 or more members disclose trades in PFE within a rolling 21-day window. Tight windows with high directional consensus score highest on the suspicion meter.
Trade Activity Timeline
Congressional buys & sells by month · last 24 months w/ activity
Who Moved First
each row = one member · sorted by earliest disclosed trade9 less-active traders not shown.
Seasonal Rhythm
Congress buy/sell pressure by month & yearEach cell = one calendar month. Green = net Congress buying, red = net selling. Intensity ∝ consensus strength. Hover for details.
Congressional Conviction Timeline
net positioning · alpha track recordMIXEDAll Disclosed Trades
| Date | Member | Action | Amount | Filing Delay | Receipt |
|---|---|---|---|---|---|
| 2026-05-15 | DRo Khanna | BUY | $1K – $15K | 25d | receipt → |
| 2026-04-13 | DRo Khanna | BUY | $1K – $15K | 28d | receipt → |
| 2026-03-13 | DGilbert Cisneros | SELL | $1K – $15K | 26d | receipt → |
| 2026-03-13 | DGilbert Cisneros | SELL | $1K – $15K | 25d | receipt → |
| 2026-02-10 | DGilbert Cisneros | BUY | $1K – $15K | 28d | receipt → |
| 2026-02-10 | DGilbert Cisneros | BUY | $1K – $15K | 27d | receipt → |
| 2026-01-22 | DRo Khanna | SELL | $1K – $15K | 15d | receipt → |
| 2025-12-31 | RJ. Hill | SELL | $100K – $250K | 26d | receipt → |
| 2025-12-31 | RJ. Hill | SELL | $100K – $250K | 23d | receipt → |
| 2025-06-17 | RJulia Letlow | BUY | $1K – $15K | 211d | receipt → |
| 2025-12-19 | DGilbert Cisneros | SELL | $1K – $15K | 25d | receipt → |
| 2025-06-17 | RJulia Letlow | BUY | $1K – $15K | 210d | receipt → |
| 2025-12-19 | DGilbert Cisneros | SELL | $1K – $15K | 24d | receipt → |
| 2025-11-18 | DGilbert Cisneros | BUY | $1K – $15K | 28d | receipt → |
| 2025-11-18 | DGilbert Cisneros | BUY | $1K – $15K | 27d | receipt → |
| 2025-09-15 | DRo Khanna | SELL | $1K – $15K | 18d | receipt → |
| 2025-09-05 | DRo Khanna | SELL | $1K – $15K | 28d | receipt → |
| 2025-08-05 | DGilbert Cisneros | SELL | $1K – $15K | 41d | receipt → |
| 2025-08-04 | RLisa McClain | SELL | $1K – $15K | 42d | receipt → |
| 2025-08-05 | DGilbert Cisneros | SELL | $1K – $15K | 38d | receipt → |
| 2025-08-04 | RLisa McClain | SELL | $1K – $15K | 39d | receipt → |
| 2025-08-04 | DRo Khanna | BUY | $1K – $15K | 36d | receipt → |
| 2025-07-16 | RLisa McClain | BUY | $1K – $15K | 29d | receipt → |
| 2025-07-16 | RLisa McClain | BUY | $1K – $15K | 28d | receipt → |
| 2025-07-01 | DRo Khanna | BUY | $1K – $15K | 37d | receipt → |
| 2025-06-03 | DJosh Gottheimer | SELL | $1K – $15K | 44d | receipt → |
| 2025-06-03 | DJosh Gottheimer | SELL | $1K – $15K | 43d | receipt → |
| 2025-06-20 | DRo Khanna | BUY | $1K – $15K | 19d | receipt → |
| 2025-06-03 | DJosh Gottheimer | SELL | $1K – $15K | 34d | receipt → |
| 2025-06-03 | DRon Wyden | SELL | $1K – $15K | 30d | receipt → |
| 2025-06-03 | DRon Wyden | SELL | $1K – $15K | 29d | receipt → |
| 2025-05-28 | DRo Khanna | BUY | $1K – $15K | 13d | receipt → |
| 2025-05-19 | DRo Khanna | BUY | $15K – $50K | 22d | receipt → |
| 2025-05-30 | DGilbert Cisneros | BUY | $1K – $15K | 10d | receipt → |
| 2025-05-30 | DGilbert Cisneros | BUY | $1K – $15K | 7d | receipt → |
| 2025-05-15 | RRobert Bresnahan | BUY | $15K – $50K | 18d | receipt → |
| 2025-05-15 | RRobert Bresnahan | BUY | $15K – $50K | 16d | receipt → |
| 2025-04-21 | RBruce Westerman | SELL | $1K – $15K | 22d | receipt → |
| 2025-04-21 | RBruce Westerman | SELL | $1K – $15K | 21d | receipt → |
| 2025-04-15 | DRo Khanna | SELL | $15K – $50K | 27d | receipt → |
| 2025-04-09 | DRo Khanna | SELL | $15K – $50K | 33d | receipt → |
| 2025-04-11 | RJefferson Shreve | SELL | $15K – $50K | 27d | receipt → |
| 2025-04-29 | DGilbert Cisneros | BUY | $1K – $15K | 8d | receipt → |
| 2025-04-29 | DGilbert Cisneros | BUY | $1K – $15K | 7d | receipt → |
| 2025-04-08 | RRobert Bresnahan | SELL | $15K – $50K | 20d | receipt → |
| 2025-03-03 | RBruce Westerman | BUY | $1K – $15K | 44d | receipt → |
| 2025-03-10 | RCarol Miller | SELL | $1K – $15K | 32d | receipt → |
| 2025-03-31 | DGilbert Cisneros | SELL | $15K – $50K | 7d | receipt → |
| 2025-02-25 | RRobert Bresnahan | BUY | $15K – $50K | 30d | receipt → |
| 2025-02-12 | DJulie Johnson | SELL | $1K – $15K | 28d | receipt → |
| 2025-02-24 | RJefferson Shreve | BUY | $15K – $50K | 13d | receipt → |
| 2025-02-13 | RJohn Boozman | SELL | $1K – $15K | 22d | receipt → |
| 2025-02-26 | DGilbert Cisneros | BUY | $1K – $15K | 8d | receipt → |
| 2025-02-13 | RJohn Boozman | SELL | $1K – $15K | 21d | receipt → |
| 2025-02-26 | DGilbert Cisneros | BUY | $1K – $15K | 6d | receipt → |
| 2025-01-15 | DJulie Johnson | SELL | $1K – $15K | 28d | receipt → |
| 2025-01-24 | DGilbert Cisneros | SELL | $1K – $15K | 18d | receipt → |
| 2025-01-22 | DRo Khanna | BUY | $1K – $15K | 15d | receipt → |
| 2025-01-17 | DRo Khanna | BUY | $1K – $15K | 20d | receipt → |
| 2024-11-15 | DRo Khanna | SELL | $15K – $50K | 20d | receipt → |
| 2024-11-13 | DRo Khanna | BUY | $1K – $15K | 22d | receipt → |
| 2024-10-21 | RLaurel Lee | BUY | $15K – $50K | 31d | receipt → |
| 2024-10-15 | DGreg Landsman | SELL | $1K – $15K | 30d | receipt → |
| 2024-10-15 | DGreg Landsman | SELL | $1K – $15K | 14d | receipt → |
| 2024-10-21 | RLaurel Lee | BUY | $15K – $50K | 2d | receipt → |
| 2024-08-27 | DRo Khanna | BUY | $1K – $15K | 10d | receipt → |
| 2024-08-06 | RC. Franklin | SELL | $15K – $50K | 14d | receipt → |
| 2024-08-01 | RC. Franklin | SELL | $1K – $15K | 19d | receipt → |
| 2024-05-03 | RTommy Tuberville | SELL | $15K – $50K | 42d | receipt → |
| 2024-05-03 | RTommy Tuberville | SELL | $15K – $50K | 42d | receipt → |
| 2024-03-04 | RRoger Williams | SELL | $1K – $15K | 100d | receipt → |
| 2024-03-01 | RRoger Williams | BUY | $1K – $15K | 103d | receipt → |
| 2024-03-01 | RRoger Williams | SELL | $1K – $15K | 103d | receipt → |
| 2024-05-29 | DRo Khanna | BUY | $15K – $50K | 7d | receipt → |
| 2024-03-04 | RRoger Williams | SELL | $1K – $15K | 87d | receipt → |
| 2024-03-01 | RRoger Williams | SELL | $1K – $15K | 90d | receipt → |
| 2024-03-01 | RRoger Williams | BUY | $1K – $15K | 90d | receipt → |
| 2024-04-23 | DRo Khanna | BUY | $1K – $15K | 13d | receipt → |
| 2024-03-25 | DRo Khanna | BUY | $1K – $15K | 11d | receipt → |
| 2024-03-20 | DRo Khanna | BUY | $15K – $50K | 16d | receipt → |
| 2024-02-27 | RTommy Tuberville | BUY | $1K – $15K | 17d | receipt → |
| 2024-02-27 | RTommy Tuberville | BUY | $1K – $15K | 17d | receipt → |
| 2024-02-13 | DRo Khanna | SELL | $15K – $50K | 22d | receipt → |
| 2024-02-13 | DRo Khanna | BUY | $15K – $50K | 22d | receipt → |
| 2024-02-02 | DRo Khanna | SELL | $15K – $50K | 3d | receipt → |
| 2024-01-31 | DRo Khanna | BUY | $1K – $15K | 5d | receipt → |
| 2023-12-11 | DSheldon Whitehouse | SELL | $1K – $15K | 38d | receipt → |
| 2023-12-14 | RJerry Moran | SELL | $1K – $15K | 34d | receipt → |
| 2023-12-18 | RShelley Capito | PARTIAL_SELL | $1K – $15K | 25d | receipt → |
| 2023-12-20 | RJohn Boozman | BUY | $1K – $15K | 19d | receipt → |
| 2023-12-28 | DJared Moskowitz | SELL | $1K – $15K | 3d | receipt → |
| 2023-07-25 | RTommy Tuberville | BUY | $1K – $15K | 34d | receipt → |
| 2023-06-12 | RTommy Tuberville | BUY | $1K – $15K | 77d | receipt → |
| 2022-01-12 | RTommy Tuberville | BUY | $1K – $15K | 593d | receipt → |
| 2021-12-21 | RJerry Moran | BUY | $1K – $15K | 615d | receipt → |
| 2020-11-17 | DJacky Rosen | EXCHANGE | $1K – $15K | 1014d | receipt → |
| 2018-12-06 | RJerry Moran | SELL | $1K – $15K | 1726d | receipt → |
| 2023-06-28 | DLois Frankel | BUY | $1K – $15K | 23d | receipt → |
| 2023-02-01 | DLois Frankel | BUY | $1K – $15K | 40d | receipt → |
| 2023-02-24 | DJared Moskowitz | PARTIAL_SELL | $1K – $15K | 4d | receipt → |